跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LATACHIMO COMBINATION OPHTHALMIC SOLUTION “NITTO” - HSA Drug Approval Details
Approvals
/
HSA
/
LATACHIMO COMBINATION OPHTHALMIC SOLUTION “NITTO”
Approved
THERAPEUTIC
LATACHIMO COMBINATION OPHTHALMIC SOLUTION “NITTO”
NITTO MEDIC CO., LTD (JAPAN)
🇸🇬 Health Sciences Authority
Approval Date
Jul 16, 2020
Approval ID
3911d12b71ef30d7
Company
NITTO MEDIC CO., LTD (JAPAN)
Type
Therapeutic
Approval Details
Approval Id
3911d12b71ef30d7
Drug Name
LATACHIMO COMBINATION OPHTHALMIC SOLUTION “NITTO”
Product Name
LATACHIMO COMBINATION OPHTHALMIC SOLUTION “NITTO”
Approval Number
SIN15974P
Approval Date
2020-07-16
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
SOLUTION, STERILE
Route Of Administration
OPHTHALMIC
Atc Code
S01ED51
Atc Item Name
timolol, combinations
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Company Detail Path
/organization/pharmaforte-singapore-pte-ltd
Active Ingredients
Latanoprost
0.05 mg/ml
Timolol Maleate
6.83 mg/ml
LATANOPROST
0.05 MG/ML
TIMOLOL MALEATE
6.83 MG/ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jul 16, 2020
Approval ID
3911d12b71ef30d7
Type
Therapeutic
Back to HSA Approvals
